Tri-Cities Nurse practitioner meets Rising Demand with Expanded Men’s Health Clinic
Richland, WA – Nurse practitioner Luke Ruzicka is expanding his men’s health practice, Redefined Health, to meet a growing demand for testosterone replacement therapy (TRT) and other related services in the Tri-Cities area. The clinic, located at 400 Columbia Point Drive, Suite 201-B in Richland, has seen important growth, with approximately 80% of its buisness currently focused on providing TRT.
Ruzicka notes that declining testosterone levels can stem from a variety of factors, including age, testicular cancer, physical injuries, and accidents. He emphasizes that there isn’t a single “normal” range for testosterone, advocating for individualized treatment plans. His approach involves extensive blood testing, analyzing both total and free testosterone levels alongside sex hormone binding globulin (SHBG) to tailor treatment – delivered via injections, patches, or pills – to each patient’s specific needs.
While many patients proactively seek treatment after experiencing symptoms, Ruzicka also reports that partners – wives and girlfriends - frequently initiate contact on their behalf. Patients undergoing TRT often report improvements in focus, drive, sleep quality, workout recovery, and sexual health.Ruzicka shared instances of patients experiencing significant positive changes, even after conventional treatments like medication had proven ineffective.
Beyond TRT, redefined Health also offers medical weight loss programs, treatments for erectile dysfunction, and peptide therapy, utilizing human growth hormone to aid recovery from athletic training, injury, and surgery.
The clinic operates on a concierge care model, with patients paying a monthly membership fee, starting at $180 for TRT, to bypass the complexities and costs associated with insurance claims and ensure greater access to their provider. This model mirrors that of several other healthcare providers in the Tri-Cities.
Ruzicka acknowledges existing misconceptions surrounding TRT, emphasizing the importance of monitoring red blood cell counts to mitigate the risk of blood clots. He also notes that TRT can suppress sperm count, perhaps leading to infertility, though this effect is frequently enough reversible. Though, he points to recent studies suggesting that TRT does not necessarily increase the risk of prostate or testicular cancers, contrary to previous concerns.
The Urology Care Foundation of the American Urological Association recognizes TRT as a valid treatment for low testosterone, and cautions against clinics offering the therapy without adequate training and oversight. Ruzicka believes that the reputation of TRT is improving as more reputable clinics emerge. He anticipates a broader adoption of TRT services in the future.
Looking ahead, Ruzicka plans to expand Redefined Health’s services to include treatment for estrogen deficiency in women, spurred by requests from patients’ wives observing positive changes in their husbands.
For more information, visit redefinedhealthclinic.com or call 509-246-6764.
